 |
PDBsum entry 6iiu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
6iiu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural basis for ligand recognition of the human thromboxane a2 receptor.
|
 |
|
Authors
|
 |
H.Fan,
S.Chen,
X.Yuan,
S.Han,
H.Zhang,
W.Xia,
Y.Xu,
Q.Zhao,
B.Wu.
|
 |
|
Ref.
|
 |
Nat Chem Biol, 2019,
15,
27-33.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Stimulated by thromboxane A2, an endogenous arachidonic acid
metabolite, the thromboxane A2 receptor (TP) plays a pivotal role in
cardiovascular homeostasis, and thus is considered as an important drug target
for cardiovascular disease. Here, we report crystal structures of the human TP
bound to two nonprostanoid antagonists, ramatroban and daltroban, at 2.5 Å
and 3.0 Å resolution, respectively. The TP structures reveal a ligand-binding
pocket capped by two layers of extracellular loops that are stabilized by two
disulfide bonds, limiting ligand access from the extracellular milieu. These
structures provide details of interactions between the receptor and antagonists,
which help to integrate previous mutagenesis and SAR data. Molecular docking of
prostanoid-like ligands, combined with mutagenesis, ligand-binding and
functional assays, suggests a prostanoid binding mode that may also be adopted
by other prostanoid receptors. These insights into TP deepen our understanding
about ligand recognition and selectivity mechanisms of this physiologically
important receptor.
|
 |
|
|
|
|
 |